Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures
Status:
Completed
Trial end date:
2019-09-30
Target enrollment:
Participant gender:
Summary
This study is designed to provide long term safety data of TRI476 in children with
inadequately-controlled partial seizures. This study is conducted in patients who complete
the core study CTRI476B1301. Blinding is maintained during the transition and dose adjustment
phase of the extension study. All patients are treated with TRI476 from the dose adjustment
phase onwards. The purpose of study is to confirm that TRI476 as adjunctive therapy is safe.